Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pal

Showing results (361-370 of 396) with videos related to

Pageof 40
Sort By:
Journal of Neurosciences in Rural Practice|May 6, 2020
Current Status of Indications, Timing, Management, Complications, and Outcomes of Tracheostomy in Traumatic Brain Injury PatientsGabriel A Quiñones-Ossa, Y A Durango-Espinosa, H Padilla-Zambrano, et al.
Iscience|May 3, 2022
Synthetic lethality-based prediction of anti-SARS-CoV-2 targetsLipika R Pal, Kuoyuan Cheng, Nishanth Ulhas Nair, et al.
The Journal of Clinical Investigation|April 1, 1989
Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipientsS A Cassol, M C Poon, R Pal, et al.
Neurochemistry International|March 15, 2011
Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expressionE K Michaelis, X Wang, R Pal, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic lethality-based prediction of anti-SARS-CoV-2 targetsLipika R Pal, Kuoyuan Cheng, Nishanth Ulhas Nair, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 1, 1997
The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccineG P Talwar, O M Singh, S K Gupta, et al.
Oncogene|August 9, 2011
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXLA E Sayan, R Stanford, R Vickery, et al.
Human Mutation|June 12, 2019
Assessment of methods for predicting the effects of PTEN and TPMT protein variantsVikas Pejaver, Giulia Babbi, Rita Casadio, et al.
Computational and Structural Biotechnology Journal|September 23, 2022
Antibody interfaces revealed through structural miningYizhou Yin, Matthew G Romei, Kannan Sankar, et al.
Oncotarget|April 9, 2019
Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced <i>NRAS</i>- or <i>BRAF</i>-mutated melanomaCarla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild, et al.
Pageof 40

Showing results (361-370 of 396) with videos related to

Sort By:
Pageof 40
Journal of Neurosciences in Rural Practice|May 6, 2020
Current Status of Indications, Timing, Management, Complications, and Outcomes of Tracheostomy in Traumatic Brain Injury PatientsGabriel A Quiñones-Ossa, Y A Durango-Espinosa, H Padilla-Zambrano, et al.
Iscience|May 3, 2022
Synthetic lethality-based prediction of anti-SARS-CoV-2 targetsLipika R Pal, Kuoyuan Cheng, Nishanth Ulhas Nair, et al.
The Journal of Clinical Investigation|April 1, 1989
Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipientsS A Cassol, M C Poon, R Pal, et al.
Neurochemistry International|March 15, 2011
Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expressionE K Michaelis, X Wang, R Pal, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic lethality-based prediction of anti-SARS-CoV-2 targetsLipika R Pal, Kuoyuan Cheng, Nishanth Ulhas Nair, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 1, 1997
The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccineG P Talwar, O M Singh, S K Gupta, et al.
Oncogene|August 9, 2011
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXLA E Sayan, R Stanford, R Vickery, et al.
Human Mutation|June 12, 2019
Assessment of methods for predicting the effects of PTEN and TPMT protein variantsVikas Pejaver, Giulia Babbi, Rita Casadio, et al.
Computational and Structural Biotechnology Journal|September 23, 2022
Antibody interfaces revealed through structural miningYizhou Yin, Matthew G Romei, Kannan Sankar, et al.
Oncotarget|April 9, 2019
Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced <i>NRAS</i>- or <i>BRAF</i>-mutated melanomaCarla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild, et al.
Pageof 40